Read + Share
Amedeo Smart
Independent Medical Education
Sargazi N, Afshari S, Nahvijou A, Daroudi R, et al. Cost-effectiveness of Pembrolizumab in advanced endometrial cancer: A systematic review. Gynecol Oncol 2026;209:146-157.PMID: 42150326
Email
LinkedIn
Privacy Policy